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Abstract
Background: Human myelopoiesis is an exciting biological model for cellular differentiation since
it represents a plastic process where multipotent stem cells gradually limit their differentiation
potential, generating different precursor cells which finally evolve into distinct terminally
differentiated cells. This study aimed at investigating the genomic expression during myeloid
differentiation through a computational approach that integrates gene expression profiles with
functional information and genome organization.
Results: Gene expression data from 24 experiments for 8 different cell types of the human
myelopoietic lineage were used to generate an integrated myelopoiesis dataset of 9,425 genes, each
reliably associated to a unique genomic position and chromosomal coordinate. Lists of genes
constitutively expressed or silent during myelopoiesis and of genes differentially expressed in
commitment phase of myelopoiesis were first identified using a classical data analysis procedure.
Then, the genomic distribution of myelopoiesis genes was investigated integrating transcriptional
and functional characteristics of genes. This approach allowed identifying specific chromosomal
regions significantly highly or weakly expressed, and clusters of differentially expressed genes and
of transcripts related to specific functional modules.
Conclusion: The analysis of genomic expression during human myelopoiesis using an integrative
computational approach allowed discovering important relationships between genomic position,
biological function and expression patterns and highlighting chromatin domains, including genes
with coordinated expression and lineage-specific functions.
Background
In recent years, the availability of the human genome
sequence disclosed novel opportunities to study biologi-
cal processes from a higher level perspective. The concur-
rent advance in bioinformatic methods, as well as in high
throughput technologies for the analysis of gene expres-
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sion profiles, allowed deepening the knowledge of
genome structure and function. In particular, several
genomic studies suggested the existence of relationships
between gene expression and genomic position. The pio-
neering work of Caron and co-workers [1] enlightened a
higher-order organization of the genome and identified
regions of increased gene expression as groups of physi-
cally contiguous highly expressed genes. The analysis of
non-random genomic distribution of genes and other
genomic features, such as GC rich regions [2-4], showed
that tissue- or organ-specific genes are often grouped in
distinct chromosomal regions [5-10]. Lee and Sonnham-
mer [11] identified a significant tendency to cluster of
genes encoding products active in the same pathway. The
correlation among co-expression and co-localization of
genes was also investigated and confirmed in different
organisms [12]. Different bioinformatic methods were
developed to identify chromosomal regions of increased
or decreased expression from transcriptional data [13-20]
and to find significant local enrichment of specific fea-
tures in genomes [21]. Some of these methodologies
based on transcriptome mapping were also successfully
used to study the correlation between expression and
position of genes in tumours or in other diseases, proving
to be effective both in identifying chromosomal aberra-
tions in cancers [15-18,20] and in discovering novel genes
potentially involved in tumorigenicity [22] and other dis-
orders [23,24].
Given these experimental evidences, the integration of
high-throughput transcriptional data with gene structural
information and functional characteristics represents a
major challenge for bioinformatics and computational
biology. Indeed, an integrated approach would allow
deciphering how the structural organization of genomes
influences its functional utilization. For instance, the
existence of tissue-specific gene clusters may be related to
the efficient activation of gene expression in a particular
cell lineage, by genetic and epigenetic mechanisms, or
related to the repression of entire chromosomal regions
containing genes expressed in a specific cell type, e.g. dur-
ing the developmental switches leading to different cell
lineages [25]. The analysis of transcriptome data in the
perspective of the genomic organization of genes could
certainly shed light not only on the aberrations leading to
pathological states but also on the physiological mecha-
nisms of all cellular processes, including cellular differen-
tiation.
Haematopoiesis is an exciting biological model for cellu-
lar differentiation since it represents a plastic process
where multipotent stem cells gradually limit their differ-
entiation potential, generating different precursor cells
which finally evolve in 8 distinct types of terminally dif-
ferentiated cells [26,27]. Myelopoiesis is the part of
hematopoiesis leading to differentiation of myelopoietic
cell lineages (erythroid, megakaryocytic, granulocytic and
mono/macrophagic). This biological process is regulated
by ordered patterns of gene expression, where specific
combinations of transcription factors or chromatin
remodelling complexes result to be responsible for the
genetic program of each hematopoietic precursor [28-30].
Many transcription factors playing a major role in the lin-
eage choice and maturation of hematopoietic cells are
known [31-33]. Several perturbation studies based on
gene inactivation and ectopic expression of lineage
restricted factors [31,34] highlighted the central role of
gene expression regulation in governing these processes.
The present study aimed at investigating the human mye-
loid differentiation through the analysis of genomic data.
Specifically, a bioinformatic framework was used to ana-
lyze the genomic organization and distribution of genes
involved in specific differentiation lineage choice. Corre-
lations between expression patterns of genes, their physi-
cal position and their biological roles were investigated.
Moreover, this genomic approach allowed identifying, in
the human genome, chromatin domains containing clus-
ters of genes relevant for specific myeloid lineages and
chromosomal regions with transcriptional activity
remaining low in myelopoietic cells, which are partially
overlapping with genomic clusters of genes related to non
hematopoietic functions.
Results
The integrated myelopoiesis gene expression dataset
Cell types and samples
The original probeset-level dataset, produced using
Affymetrix GeneChip HG-U133A, includes gene expres-
sion data, relative to 22,283 probesets, in 24 experiments
generated from 8 different cell types of the human myelo-
poietic lineage: hematopoietic stem/progenitor cells
(CD34+ cells), myeloid precursors (myeloblasts, mono-
blasts, erythroblasts and megakaryoblasts) and terminally
differentiated cells (monocytes, neutrophils and eosi-
nophils). The relationships among different cell types
along the myeloid differentiation process and the number
of replicates for each cell type are summarized in Figure
1A.
Annotation and filtering
From the original dataset, we selected only probesets
reportedly associated to a unique human gene. Among
them, those probeset/gene matches showing, according to
the GeneAnnot database [35], either sensitivity and spe-
cificity score of 1 were chosen, thus obtaining 16,065
expression data vectors reliably associated to 11,138 dif-
ferent human genes. An ad hoc data filtering procedure
was used to eliminate redundancy in expression data, i.e.
multiple probesets per gene, by associating a single relia-BMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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Gene expression dataset Figure 1
Gene expression dataset. A) The gene expression dataset analyzed comprises cell samples from different levels of myeloid 
differentiation process (stem/progenitor cells, precursors and terminally differentiated cells). The graph describes relationships 
between the cellular contexts analyzed within myeloid differentiation tree. For each cell type, the number of samples examined 
with independent microarray experiments is indicated in brackets. B) Dendrogram obtained by unsupervised hierarchical clus-
tering on gene expression data matrix. Pearson correlation and average were used as similarity measure and linking method, 
respectively.
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ble expression vector to each EntrezGeneID. The filtered
data set consisted of 10,014 gene expression vectors.
Finally, when establishing the correspondence between
each gene and genomic position, further 589 genes with
ambiguous genomic location, were discarded. The result-
ing myelopoiesis expression data matrix included 9,425
genes, each reliably associated to a unique genomic posi-
tion, identified as the bp interval of gene span, and to a
single expression vector (Additional file 1). Although the
myelopoiesis gene expression data matrix represents only
a subset of all human genes, corresponding to about one
half of the 18,349 known protein-coding genes reported
in EntrezGene database, it's worthwhile noting that there
is no significant deviation from chromosomal distribu-
tion of the 9,425 genes included in our data matrix and
the chromosomal distribution of the 18,349 protein-cod-
ing human genes (p-value >> 0.05; data not shown).
Gene expression data analysis
Unsupervised analysis
Unsupervised hierarchical clustering was performed to
verify if the gene expression profiles of the data matrix,
following the probeset annotation and filtering process
described above, were able to correctly group the various
phenotypes, including data from public repositories. As
shown in Figure 1B, different cell types are quite well sep-
arated by unsupervised analysis performed on the whole
gene expression profiles.
Identification of genes constitutively expressed or silent during 
myelopoiesis
The selection of silent and expressed genes didn't rely only
on Affymetrix detection because, even if trustworthy,
detection is actually only a measure of signal quality asso-
ciated to each probeset, rather than an evaluation of the
real transcriptional status of a gene. Therefore, in order to
identify a threshold for discriminating between silent and
expressed genes, we analyzed the signal values distribu-
tion of the probeset-level dataset, considering only log2
signal values corresponding to probesets with "P" detec-
tion call. The expression value of 5.44, corresponding to
the 10th  percentile of signal values distribution, was
selected as threshold. Then, this threshold was used to dis-
criminate between genes not expressed at a detectable
level, i.e. silent, and expressed genes, regardless of the
detection call, either Present or Absent, associated to each
gene. For each of the 8 cell types in the gene expression
data matrix, we considered silent those genes showing
median expression value, across replicates, lower than the
threshold. Then we identified as expressed those genes
with median expression value higher than the selected
threshold.
Merging of the lists of genes expressed in different samples
showed that a total of 5,296 genes are transcribed in every
examined cell type of the myelopoietic lineage, and hence
constitutively expressed during myelopoiesis (Additional
file 2). Conversely, 1,418 genes resulted to be silent in all
the considered myeloid cell types (Additional file 3).
Functional characterization of genes constitutively
expressed during myelopoiesis was attempted, by exami-
nation of biological processes involving their products,
according to the functional classification of DAVID 2006
[36]. Gene Ontology terms, associated to constitutively
expressed genes, and significantly more represented than
expected (p-value < 0.01), refer mainly to basic cellular
biological processes (energy metabolism, synthetic and
catabolic metabolism of biomolecules and biopolymers);
gene expression (mRNA processing, RNA splicing) and
post-translational protein modification or transport; and
to regulation of cell cycle or to apoptosis (Figure 2A and
Additional file 2). All of these functions are necessary for
basal cell activity and hence are also required by myelo-
poietic cells, along all of the differentiation steps, as well
as by other cell types.
Significantly over-represented Gene Ontology terms, asso-
ciated to silent genes during myelopoiesis, refer to biolog-
ical processes related to development or function of non-
hematopoietic organs or systems (Figure 2B and Addi-
tional file 3). Among these: sensory perception, transmis-
sion of nerve impulse, muscle contraction, muscle
development, nervous system development, skeletal
development and digestion. All of these processes are
clearly not involved in myelopoiesis and it is reasonable
to identify corresponding genes as "not expressed" along
the entire differentiation process.
Identification of genes differentially expressed in commitment phase
We then focused to the commitment phase of myelopoie-
sis, i.e. the phase of lineage choice for the proliferating
stem cells. The four different myelopoietic precursor cell
types were pairwise compared with CD34+ cells, by using
SAM, to identify genes differentially expressed in the com-
mitment phase of stem cell towards each maturation proc-
ess. Using fairly stringent conditions (minimum fold
change = 2; number of permutations = 100 and estimated
FDR < 0.01), genes significantly up-regulated and down-
regulated in each lineage choice were identified (Addi-
tional file 4). The number of genes differentially expressed
when comparing stem cells versus erythroblasts, myelob-
lasts, monoblasts and megakaryoblasts are respectively
492, 47, 403 and 350, thus showing that myeloblasts are
the precursor cells most similar to CD34+ cells. It is worth
note that about the two thirds of differentially expressed
genes in each lineage choice are specific of a single differ-
entiation program (e.g. 273 out of 403 genes differentially
expressed in CD34+ cells versus monoblasts are specifi-
cally differentially expressed only in this comparison).BMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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Functional classification of constitutively expressed or silent genes during myelopoiesis Figure 2
Functional classification of constitutively expressed or silent genes during myelopoiesis. Functional classification 
was performed using the functional annotation chart of DAVID 2006 and significantly over-represented Gene Ontology Biolog-
ical Process categories (p-value < 0.01) were identified. Groups of functional categories were defined using a custom Gene 
Ontology SLIM and R script [69]. Complete lists of over-represented functional classes are reported in Additional file 2 and 3.
A
Main groups of overírepresented functional
classes of constitutively expressed genes
B
Main groups of overírepresented functional
classes of silent genesBMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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Gene Ontology terms, associated to genes significantly
up-regulated in each considered commitment phase, and
significantly more represented than expected (p-value <
0.01) are reported in Table 1. Enriched terms refer to pecu-
liar biological role of each differentiation lineage. Indeed
genes up-regulated in erythroblasts are mainly involved in
heme biosynthesis and erythroid differentiation, or
encode erythrocytes antigens (see also Table 2). Similarly,
megakaryoblasts showed increased expression of genes
consistent with platelet biology, being related to blood
coagulation and platelet activation or to biosynthesis of
steroids and particularly of thromboxanes; myeloblasts
up-regulated functions related to granulocytes biology,
such as immune and defense response; and monoblasts
over-expressed genes involved in immune and defense
response, or immune and macrophage cell activation,
which are peculiar biological roles of monocytes (Table
2).
Genomic distribution of myelopoiesis genes
Chromosomal distribution
We first considered the distribution across chromosomes
of expressed genes during myelopoiesis. For each consid-
ered cell type the chromosomal expression index was cal-
culated as the percentage of expressed genes per
chromosome (Figure 3).
Chromosomes 16, 19, 21 and 22 show high expression
indexes across diverse cell types, whereas, chromosomes
4, 13 and 18 have low expression indexes.
Following these indirect indications of a possible correla-
tion among genomic position of genes and their expres-
sion pattern during myelopoiesis, we investigated the
positional clustering of genes similar for expression char-
acteristics in the considered cell types, as well as the exist-
ence of chromosomal regions homogeneous in
expression behavior.
Regions highly expressed identified by LAP
Using an ad hoc customized version of LAP (Locally
Adapting Procedure[20] we searched for genomic regions
significantly highly expressed. Minimum of gene expres-
sion levels across replicates was adopted as statistic for
ranking probes in order of strength of expression. High
peaks of the statistic, resulting significant after 100,000
permutations and with the q-value threshold set to 0.05,
correspond to genomic regions with highest expression
(Figure 4).
One region was found highly expressed both in CD34+
cells and in precursor cells, including 18 genes of gene
expression data matrix and spanning 7.21 megabases
(Mb) on chromosome 2p14-p15. The functional analysis
of these 18 genes showed that most represented categories
are protein transport and Golgi apparatus. The region,
considering the whole set of EntrezGenes, contains 59
genes including 30 hypothetical proteins. Known genes
encode proteins for basic cellular functions presumably
relevant in every cell types: such as protein transport
(XPO1, VPS54, AFTPH and RAB1A); amino acids glyco-
sylation in Golgi apparatus (B3GNT2); Krebs cycle
(MDH1); protein ubiquitination (USP34); signal trans-
duction (PPP3R1); protein folding (CCT4) [37] and
cytoskeleton structure (ACTR2). Finally this chromo-
somal area contains MEIS1, a regulator of proliferation
and differentiation of myelopoietic precursors [38].
Regions weakly expressed identified by LAP
The set of genomic regions with low transcriptional activ-
ity in each considered cell type was identified by using
LAP software. Maximum gene expression level across rep-
licates was adopted as statistic and the settings of number
of permutations and q-value threshold were as above.
Thus, significant low peaks corresponded to genomic
regions with lowest expression.
A total of 28 weakly expressed chromosomal regions,
spanning 408 Mb in total, were identified in CD34+ cells.
By comparing regions weakly expressed in CD34+ cells
with those weakly expressed in precursor cells, we verified
that 70% of these regions stably show low transcriptional
activity during commitment phase of myelopoiesis: 21
regions are stably silenced, spanning 288 Mb and contain-
ing in total 788 genes (Figure 4). In addition, these
regions stably silenced in commitment phase seem to be
stably silenced also during terminal differentiation,
because 85% of them are also weakly expressed in differ-
entiated cells i.e. monocytes, neutrophils and eosinophils
(data not shown).
The comparison of regions weakly expressed in CD34+
cells with the non redundant list of 1,055 genes differen-
tially expressed in commitment phase, generated by merg-
ing previously mentioned lists of differentially expressed
genes, showed that 89 genes differentially expressed
(8.4%) fall within CD34+ weakly expressed regions. This
value is significantly lower than expected by chance, as
calculated using hypergeometric distribution (p-value =
0.002).
Then, the whole set of human EntrezGenes was consid-
ered, independently to the fact that they were or not rep-
resented in the myelopoiesis data matrix. Accordingly to
Gene Ontology classification, human genes were associ-
ated to specific functional modules. A functional module
was defined as a specific biological process or a group of
functionally related biological processes: one or more
Gene Ontology terms were used to filter EntrezGenes in
order to define functional modules genes (see AdditionalBMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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Table 1: Functional classification of genes differentially expressed during commitment phase
GO biological process terms p-value GO biological process terms p-value
Genes up-regulated in erythroblasts
heme biosynthesis 8.3593E-09 tRNA metabolism 4.7686E-04
heme metabolism 4.1178E-08 nitrogen compound metabolism 0.0011
pigment biosynthesis 7.8243E-08 cholesterol biosynthesis 0.0021
porphyrin biosynthesis 8.0158E-08 amino acid activation 0.0022
pigment metabolism 1.8805E-07 tRNA aminoacylation for protein 
translation
0.0022
porphyrin metabolism 2.5313E-07 tRNA aminoacylation 0.0022
carboxylic acid metabolism 3.5431E-07 electron transport 0.0023
organic acid metabolism 4.0819E-07 amino acid and derivative metabolism 0.0025
secondary metabolism 5.8601E-07 amine metabolism 0.0037
heterocycle metabolism 4.7133E-06 lipid metabolism 0.0037
cellular biosynthesis 6.9372E-06 steroid biosynthesis 0.0041
cofactor metabolism 1.0534E-05 cholesterol metabolism 0.0041
cofactor biosynthesis 1.9914E-05 iron ion homeostasis 0.0042
generation of precursor metabolites and 
energy
3.9831E-05 sterol biosynthesis 0.0045
cellular metabolism 5.6290E-05 mitotic cell cycle 0.0059
lipid biosynthesis 1.6546E-04 alcohol metabolism 0.0060
cellular lipid metabolism 2.3765E-04 sterol metabolism 0.0061
amino acid metabolism 4.3568E-04
Genes up-regulated in megakaryoblasts
hemostasis 0.0010 positive regulation of cell proliferation 0.0024
endocytosis 0.0011 steroid metabolism 0.0024
cellular lipid metabolism 0.0012 lipid biosynthesis 0.0026
wound healing 0.0014 regulation of receptor mediated 
endocytosis
0.0034
lipid metabolism 0.0020 localization of cell 0.0049
alcohol metabolism 0.0020 cell motility 0.0049
regulation of body fluids 0.0024 cytoskeleton organization and biogenesis 0.0081
transport 0.0024 cholesterol biosynthesis 0.0089
Genes up-regulated in monoblasts
response to biotic stimulus 6.3071E-15 antimicrobial humoral response 3.1669E-04
immune response 2.8466E-13 detection of stimulus 6.8750E-04
defense response 7.3698E-13 protein kinase cascade 0.0010
response to pest, pathogen or parasite 1.2074E-12 wound healing 0.0014
response to other organism 2.4524E-12 intracellular signaling cascade 0.0017
response to external stimulus 1.0443E-10 positive regulation of cellular process 0.0017
response to stimulus 8.1038E-10 endocytosis 0.0019
response to wounding 1.3630E-09 I-kappaB kinase/NF-kappaB cascade 0.0025
response to stress 2.1560E-08 lymphocyte activation 0.0031
inflammatory response 3.0602E-08 blood coagulation 0.0034
cell communication 5.0323E-07 taxis 0.0035
signal transduction 7.7480E-07 chemotaxis 0.0035
organismal physiological process 8.0044E-07 innate immune response 0.0037
response to pathogen 3.1842E-06 coagulation 0.0038
humoral immune response 3.4723E-05 locomotory behavior 0.0044
detection of biotic stimulus 4.6946E-05 hemostasis 0.0045
response to bacteria 6.7200E-05 carbohydrate metabolism 0.0048
response to pathogenic bacteria 9.7266E-05 cell surface receptor linked signal 
transduction
0.0059
immune cell activation 1.0815E-04 positive regulation of biological process 0.0064
cell activation 1.2116E-04 macrophage activation 0.0093
humoral defense mechanism (sensu 
Vertebrata)
1.4837E-04 regulation of body fluids 0.0097
antimicrobial humoral response (sensu 
Vertebrata)
2.8361E-04
Genes up-regulated in myeloblasts
carboxylic acid metabolism 2.2728E-05 defense response 0.0018
organic acid metabolism 2.3815E-05 response to biotic stimulus 0.0025
cellular biosynthesis 7.1605E-04 immune response 0.0048
biosynthesis 0.0016 positive regulation of cell proliferation 0.0069
Gene expression data for each precursor cell type (erythroblasts, megakaryoblasts, monoblasts and myeloblasts) were compared with CD34+ cells gene expression data 
using SAM analysis to identify differentially expressed genes. Significantly over represented (p-value < 0.01) Gene Ontology Biological Process terms are reported for each of 
the examined lists of up-regulated genes.BMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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Table 2: Relevant functional groups of differentially expressed genes
Function Genesymbol Full name
Genes up-regulated in erythroblasts
heme biosynthesis CPOX coproporphyrinogen oxidase
heme biosynthesis ALAD aminolevulinate, delta-, dehydratase
heme biosynthesis ALAS2 aminolevulinate, delta-, synthase 2
heme biosynthesis FECH ferrochelatase (protoporphyria)
heme biosynthesis HMBS hydroxymethylbilane synthase
heme biosynthesis PPOX protoporphyrinogen oxidase
heme biosynthesis UROD uroporphyrinogen decarboxylase
heme biosynthesis UROS uroporphyrinogen III synthase (congenital 
erythropoietic porphyria)
erythroid differentiation GATA1 GATA binding protein 1 (globin transcription 
factor 1)
erythroid differentiation TAL1/SCL T-cell acute lymphocytic leukemia 1
erythrocytes antigens DARC Duffy blood group, chemokine receptor
erythrocytes antigens CD58/LFA-3 CD58 molecule
erythrocytes antigens EPB42 erythrocyte membrane protein band 4.2
erythrocytes antigens ERAF erythroid associated factor
erythrocytes antigens CD36 CD36 molecule (thrombospondin receptor)
erythrocytes antigens GYPE glycophorin E
Genes up-regulated in megakaryoblasts
blood coagulation and platelet activation ADRA2A adrenergic, alpha-2A-, receptor
blood coagulation and platelet activation GP5 glycoprotein V (platelet)
blood coagulation and platelet activation GP6 glycoprotein VI (platelet)
blood coagulation and platelet activation GP9 glycoprotein IX (platelet)
blood coagulation and platelet activation P2RY1 purinergic receptor P2Y, G-protein coupled, 1
blood coagulation and platelet activation PROS1 protein S (alpha)
blood coagulation and platelet activation THBS1 thrombospondin 1
blood coagulation and platelet activation VWF von Willebrand factor
biosynthesis of steroids LDLRAP1 low density lipoprotein receptor adaptor 
protein 1
biosynthesis of steroids TM7SF2 transmembrane 7 superfamily member 2
biosynthesis of steroids SREBF1 sterol regulatory element binding transcription 
factor 1
biosynthesis of steroids SREBF2 sterol regulatory element binding transcription 
factor 2
biosynthesis of steroids CYB5R3 cytochrome b5 reductase 3
biosynthesis of steroids VLDLR very low density lipoprotein receptor
biosynthesis of steroids ALOX12 arachidonate 12-lipoxygenase
biosynthesis of steroids LTC4S leukotriene C4 synthase
biosynthesis of steroids PTGS1/COX1 prostaglandin-endoperoxide synthase 1 
(prostaglandin G/H synthase and 
cyclooxygenase)
biosynthesis of steroids TBXAS1 thromboxane A synthase 1 (platelet, 
cytochrome P450, family 5, subfamily A)
Genes up-regulated in myeloblasts
regulation hemopoietic cells proliferation LIF leukemia inhibitory factor (cholinergic 
differentiation factor)
inflammatory response ALOX5AP arachidonate 5-lipoxygenase-activating protein
regulation of myeloid cells differentiation TIMP1 TIMP metallopeptidase inhibitor 1
Genes up-regulated in monoblasts
mono/macrophage activation CD93 CD93 molecule
mono/macrophage activation CD40 CD40 molecule, TNF receptor superfamily 
member 5
mono/macrophage activation TLR1 toll-like receptor 1
mono/macrophage activation TLR6 toll-like receptor 6
mono/macrophage activation ICAM1 intercellular adhesion molecule 1 (CD54), 
human rhinovirus receptor
mono/macrophage activation CCL2 chemokine (C-C motif) ligand 2
mono/macrophage activation FCGR1A Fc fragment of IgG, high affinity Ia, receptor 
(CD64)
mono/macrophage activation C3AR1 complement component 3a receptor 1BMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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mono/macrophage activation CD163 CD163 molecule
mono/macrophage activation IFNGR1 interferon gamma receptor 1
mono/macrophage activation IFNGR2 interferon gamma receptor 2 (interferon 
gamma transducer 1)
mono/macrophage activation CSF1R colony stimulating factor 1 receptor
inflammatory response IL6 interleukin 6 (interferon, beta 2)
inflammatory response CCR1 chemokine (C-C motif) receptor 1
inflammatory response IL1RN interleukin 1 receptor antagonist
inflammatory response TLR8 toll-like receptor 8
inflammatory response PLA2G7 phospholipase A2, group VII (platelet-activating 
factor acetylhydrolase, plasma)
inflammatory response SELPLG selectin P ligand
proteins of monocytic granules CTSB cathepsin B
proteins of monocytic granules CTSD cathepsin D (lysosomal aspartyl peptidase)
proteins of monocytic granules RNASE1 ribonuclease, RNase A family, 1 (pancreatic)
proteins of monocytic granules RNASE6 ribonuclease, RNase A family, k6
proteins of monocytic granules DNASE2 deoxyribonuclease II, lysosomal
fibrogenic cytokine TGFa transforming growth factor, alpha
dendritic cells differentiation IL3RA interleukin 3 receptor, alpha (low affinity)
The table reports a selected list of genes up-regulated and strictly related to peculiar biological role of each lineage. Significantly over-expressed 
genes were identified performing pairwise comparisons between each precursor cell type and CD34+ cells, using SAM analysis with fairly stringent 
conditions. This constitute a partial list of differentially expressed genes: complete lists are available in Additional file 4.
Table 2: Relevant functional groups of differentially expressed genes (Continued)
Chromosomal expression index Figure 3
Chromosomal expression index. For each considered cell type the chromosomal expression index (CEI) was calculated, 
for each chromosome, as the percentage of genes expressed over the total number of genes considered. Across the different 
cell types, chromosomes 16, 19, 21 and 22 show relatively high CEI, whereas, chromosomes 4, 13 and 18 have relatively low 
CEI.
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file 5 for details). Genes pertaining to 8 functional mod-
ules related to development or function of non-hemat-
opoietic organs were identified: embryonic development,
epidermis development, eye development, muscle devel-
opment and function, nervous system development, skel-
etal development, spermatogenesis, visual perception.
For each non-hematopoietic module we identified, by
using REEF (REgionally Enriched Features) [21], posi-
tional enrichment of module-related genes (sliding win-
dow = 1 Mb; window shift = 200 KB; q-value cut-off =
0.05; min number of genes in cluster = 2) (Additional file
5).
A comparison of these clusters with regions stably weakly
expressed during commitment phase of myelopoiesis,
identified with LAP, showed overlap with clusters related
to functional modules of muscle development or func-
tion, nervous system development, skeletal development
and visual perception (Additional file 5).
We then focused on three peculiar genomic regions iden-
tified as stably expressed at low level by LAP (q-value <
0.01) and partially overlapping functional modules clus-
ters identified by REEF (Additional file 5). Complete lists
of human EntrezGenes included in these regions were
retrieved (Additional file 6). The first region, located on
chromosome 2q24-q31 (spanning 1.29 Mb), contains
only 16 genes: among them 1 hypothetical protein; 1 gene
of visual perception functional module (BBS5); LRP2, that
could have a role in development of non hematopoietic
organs [39]; sarcosin (KBTBD10), involved in muscle con-
traction [40]; ABCB11 and G6PC2 relevant in hepatocytes
respectively for bile salt transport and gluconeogenesis. A
second region is on chromosome 12q21 (spanning 9.36
Mb) and contains 37 genes including 9 genes for hypo-
thetical or unknown function proteins; 2 genes of muscle
development functional module as indicated by Gene
Ontology (MYF5 and MYF6); CART1, that is involved in
muscle and skeletal development [41]; and synaptic trans-
mission genes (NTS [42], SYT1 [43] and LIN7A/Veli [44]).
Finally, the third region, on chromosome 2q33-q34
(spanning 8.41 Mb), contains 58 genes including 26
genes for hypothetical or unknown function proteins:
genes belonging to functional modules of nervous system
development (ADAM23  [45]) and of visual perception
Highly and weakly expressed regions Figure 4
Highly and weakly expressed regions. The graph on the left summarizes the genomic distribution of genes included in 
gene expression data matrix (vertical grey lines) and points out chromosomal regions stably highly (red box) or weakly (blue 
box) expressed during commitment phase of myelopoiesis. In the table on the right details on the outlined regions are showed.
7 4.64 X: 136476011 - 141120742
60 15.39 X: 95826366 - 111212660
6 1.41 20: 16200748 - 17610840
7 4.23 17: 64586441 - 68819738
28 15.94 12: 74160800 - 90100937
28 8.32 12: 14409877 - 22729910
19 7.08 11: 98397080 - 105474629
15 10.67 11: 19328846 - 29995064
30 12.06 7: 115362437 - 127427366
43 15.64 7: 82831157 - 98472036
62 32.03 6: 69404157 - 101435961
37 15.79 4: 108754271 - 124544357
35 8.47 4: 72078255 - 80548396
25 7.13 4: 37262249 - 44395959
63 25.59 3: 149898354 - 175483810
73 16.76 2: 203453574 - 220214936
62 24.53 2: 165057578 - 189585717
16 6.42 2: 105224631 - 111641054
56 10.3 1: 194887763 - 205186430
25 8.99 1: 179719338 - 188713382
91 37.08 1: 61919306 - 98998642
# genes Span (Mb) Weakly expressed regions
18 7.21 2: 61268185 - 68478086
# genes Span (Mb) Highly expressed regionBMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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(gamma-crystallins CRYGA and CRYGD that are structural
constituent of crystallin) as indicated by Gene Ontology.
Even if Gene Ontology classification wasn't able to high-
light their functional correlation, this region contains fur-
ther genes involved in non-hematopoietic functional
modules, such as neurogenesis (ERBB4 [46], CREB1 [47]
and MAP2 [48]); and other gamma-crystallins related to
visual perception (CRYGB,  CRYGC  and pseudogenes
CRYGEP1 and CRYGFP1).
Clusters of differentially expressed genes
Genomic distribution of differentially expressed genes in
each specific lineage of differentiation as compared with
CD34+ cells was analyzed by REEF (Additional file 7). Sig-
nificant clusters were identified when analyzing most of
the differentially expressed gene lists (sliding window
width = 1 Mb, shift = 200 Kb, minimum selected features
per clusters = 3 and q-value cut-off = 0.05)(Table 3 and
Figure 5). The number of gene expression data matrix
genes, included into clusters of significantly up-regulated
(or down-regulated) genes and showing higher (or lower)
expression level in corresponding precursor versus CD34+
cells, results to be significantly higher than expected by
chance (p < = 0.01), accordingly with hypergeometric dis-
tribution (Table 3). Thus there is a common trend in gene
expression within clusters identified from significantly
differentially expressed genes. Furthermore, the whole set
of EntrezGenes included into these regions was consid-
ered and their functional classification evaluated using
DAVID 2006 [36] to identify over-represented Gene
Ontology biological process terms. The most interesting
functional classes are found among functional categories
within genes of up-regulated clusters in monoblasts: they
are clearly consistent with biological role of mono/macro-
phagic lineage and include classes related to immune and
defense response, antigen processing and presentation,
response to pathogens and cell motility (data not shown).
Deeper examination of clusters of genes up-regulated in
monoblasts (Figure 5) revealed some chromatin domains
possibly related to monocytic function that were identi-
fied as chromosomal regions showing a good correlation
among biological function, genomic position and gene
expression pattern. As example we can consider the first
cluster of up-regulated genes in monoblasts: this cluster,
on chromosome 1q23 (spanning 2 Mb), contains 5 genes
significantly up-regulated in monoblasts as compared
with CD34+: among them HSPA6 (HSP70B) [49], regulat-
ing monocytes maturation towards dendritic cells;
FCER1G  [50], IgE receptor subunit expressed also in
monocytes;  SLAMF8  (BLAME) [51] and SLAMF1  [52],
Table 3: Clusters of differentially expressed genes
Clusters
Differential 
expression VS 
CD34+ cells
Total number of 
differentially 
expressed genes
Number of  
clusters
Total number of 
differentially 
expressed genes 
in  clusters
Total number of 
data matrix 
genes in  
clusters
Total number of 
EntrezGenes in  
clusters
p-value
Erythroblasts up-
regulated genes
269 7 26 151 360 7.94E-05
Erythroblasts 
down-regulated 
genes
223 4 14 54 127 0.0088
Megakaryoblasts 
up-regulated genes
214 7 25 138 379 0.0035
Megakaryoblasts 
down-regulated 
genes
136 1 3 7 18 0.0033
Monoblasts up-
regulated genes
277 7 24 166 439 0.0101
Monoblasts down-
regulated genes
1 2 6 0000 n d
Myeloblasts up-
regulated genes
3 2 0000 n d
Myeloblasts down-
regulated genes
1 5 0000 n d
REEF software was used to analyse the genomic distribution of differentially expressed genes and to find significant positional enrichments (q-value 
< 0.05). Columns 2 and 3 indicate the total number of differentially expressed genes in the human genome and the number of clusters identified by 
REEF. In the following three columns, the numbers of differentially expressed genes, genes represented in the myelopoiesis data matrix and 
EntrezGenes falling in identified clusters are reported. The numbers of genes represented in the myelopoiesis data matrix showing up- or down-
regulation, respectively for clusters of significantly up- or down-regulated genes, results to be higher than expected by chance, accordingly with 
hypergeometric distribution (p < = 0.01). Calculated p-values are reported in the last column. Further details concerning each cluster are reported 
in Additional file 7.BMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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that are involved in lymphocytes activation. This genomic
region contains a total of 73 EntrezGenes including 11
hypothetical proteins; eight IgG receptors (FCGR2A,
FCGR2B, FCGR2C, FCGR3A, FCGR3B, FCRLM1, FCRLM2,
FCRL6); and other antigens, belonging to SLAM family,
that are involved in regulation of leucocytes activity
(CD48  [53];  CD84  [54];  CD244,  SLAMF9,  SLAMF6,
SLAMF7, Ly9 [55]). More genes related to mono/macro-
phagic functions can be found also within the other clus-
ters of up-regulated genes, such as the genes of MHC class
II, involved in antigen presentation.
Discussion
Although myelopoiesis has been extensively studied,
there are still many unclear aspects, especially concerning
the genetic control of this process. In the present work,
normal human myelopoiesis was analyzed at the genomic
level, coupling gene expression data with advanced bioin-
formatics tools and knowledge on sequence and annota-
tion of the human genome. Specifically, information on
gene transcription, function and genomic localization
were integrated and analyzed to unravel relationships
between the organization and utilization of the genome
and the control of the transcriptional machinery during
the differentiation process of the hematopoietic stem cell.
Apart from its biological relevancy, myelopoiesis repre-
sents a perfect model system for the application of a novel
computational framework able to integrate multiple types
of genomic data. Indeed, hematopoietic cells have the
advantage to grow in suspension as isolated, while most
tissues are normally contaminated by different and non
tissue-specific cell types. This growing modality allows
obtaining hematopoietic samples characterized by high
purity, a crucial characteristic to generate reliable gene
expression data. Even though precursor cells were
obtained by means of in vitro differentiation of hemat-
opoietic stem cells, differentiation protocols have been
deeply tested and standardized by our laboratory in order
to obtain precursors with biological characteristics and
differentiation potentials equivalent to in vivo cells:
indeed they preserve the same capability to generate ter-
minally differentiated cells [34,56-58].
Clusters of differentially expressed genes Figure 5
Clusters of differentially expressed genes. The graph on the left summarizes the genomic distribution of genes included in 
gene expression data matrix (vertical grey lines) and points out clusters of significantly up-regulated genes in a specific precur-
sor cell type versus in comparison with CD34+ stem/progenitor cells: erythroblasts (red box), megakaryoblasts (yellow box) 
and monoblasts (green box). In the table on the right details on the outlined regions are showed.
31 1.8 19: 55600000 - 57400000
28 1.4 19: 40200000 – 41600000
26 1.8 16: 30400000 – 32200000
9 1.4 12: 7200000 – 8600000
17 1.4 11: 59600000 – 61000000
25 1.8 6: 32400000 – 34200000
30 2 1: 158000000 – 160000000
# genes Span (Mb) Monoblasts
35 2 X: 152400000 – 154400000
10 1.4 22: 16200000 - 17600000
21 1.2 14: 22000000 - 23200000
24 1.8 6: 43000000 - 44800000
10 1.6 5: 147800000 - 149400000
4 1.2 2: 32600000 - 33800000
34 2 1: 148400000 - 150400000
# genes Span (Mb) Megakaryoblasts
22 1.2 X: 153200000 - 154400000
22 1.8 X: 47800000 - 49600000
25 2 19: 5400000 - 7400000
21 1.6 15: 38200000 - 39800000
24 1.8 6: 43000000 - 44800000
16 2 1: 42800000 - 44800000
21 1.6 1: 27800000 - 29400000
# genes Span (Mb) ErythroblastsBMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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A meta-analysis approach allowed integrating proprietary
and public available gene expression experiments and to
construct a fairly broad dataset of transcriptional data for
different cell types, representing distinct lineages and dis-
tinct steps of myeloid differentiation. In particular, raw
microarray data (Affymetrix .CEL files) were obtained for
a total of 24 samples from 8 different cell types of all mye-
lopoietic lineages, representing a reference dataset for a
comprehensive analysis of genomic expression during cell
differentiation. Since sample size is a critical issue in all
microarray studies, stringent cut-offs were used in every
statistical analysis that was performed, in order to
strengthen the analytical results. To further enrich the
number of sample replicates, public repositories of micro-
array data were also searched to identify high quality raw
data obtained using the same Affymetrix GeneChips.
Unfortunately, only few samples resulted to be biologi-
cally comparable to the proprietary data and, in particu-
lar, we could not identify additional samples concerning
precursor cells. All samples were analyzed using the same
generation of Affymetrix microarrays, i.e. HG-U133A,
thus exploiting the high reliability and reproducibility of
Affymetrix chips [59,60] and avoiding possible biases due
to platform comparisons. Since the adopted approach
involved mapping of transcriptional data on the genome
and the analysis of connections between gene expression
and gene position, the annotation of the microarray
probesets has been taken into serious consideration.
Although precise and regularly up-dated, Affymetrix
probesets annotation has been demonstrated to present
some criticalities [35,61]. Therefore, we applied an ad-hoc
annotation procedure exploiting the information of the
GeneAnnot database, in which the quality, reliability, and
annotation of each probeset is quantified in terms of spe-
cificity and sensitivity scores. To strengthen our approach,
we decided to select for further analysis only those
probesets associated by GeneAnnot to a single gene with
the maximal specificity and sensitivity, i.e. 1. Further-
more, we considered the issue of probeset redundancy,
combining the expression data when multiple probesets
were annotated to the same gene. Specifically, a jackknife
procedure, applied to the signals of multiple probesets
associated to the same gene, removed outlying probeset
and generated a unique expression value only from highly
correlated probesets. The pre-processing steps resulted in
a gene expression matrix, composed of high-quality gene
expression data for 9,425 well annotated genes. Although
reduced in size as compared to the number of probes con-
tained in the Affymetrix array, the genes represented in the
myelopoiesis data matrix are a representative and compre-
hensive sample of all human genes.
An unsupervised hierarchical clustering of the re-anno-
tated data matrix indicated that the integrated gene
expression data contain information to separate different
cell types in accordance with their morphological and
functional classification, also suggesting that the inclu-
sion of data from publicly available repository didn't
cause any bias in the dataset (see Fig. 1B).
A classic supervised analysis of gene expression data was
carried out to select genes constitutively expressed or
silent during myelopoiesis and to identify, using SAM,
genes differentially expressed during commitment phase
of different lineages. The functional classification of
selected gene lists confirmed the current biological knowl-
edge and helped shedding light on myelopoiesis. Indeed,
over-represented functional classes of constitutively
expressed genes are mainly basic cellular functions,
expected to be active in each cell type, such as metabolism
or gene expression related functions. Furthermore silent
genes are mainly functionally classified in development or
function of non-hematopoietic organs or tissues, as nerv-
ous system, muscle or skeletal development, synaptic
transmission and muscle contraction. A similar approach
was also applied to the analysis of differential gene expres-
sion during commitment phase of each myelopoietic lin-
eage. The functional classification of differentially
expressed genes identified interesting peculiarities of each
cell lineage. Erythroblasts showed up-regulation of heme
biosynthesis genes, together with other erythrocytes anti-
gens and genes involved in erythroid differentiation; meg-
akaryoblasts up-regulated many genes relevant for blood
coagulation and platelet function, whereas in monoblasts
genes important for mono/macrophage activation and
function, involved in inflammatory response and coding
for monocytic granules proteins, were over-expressed.
Finally, the expression profiles of myeloblasts and CD34+
resulted less divergent, consistently with previous biolog-
ical evidences proving that myeloblasts are the precursor
cells most similar to the hematopoietic precursor/stem
cells [56]. All these results should facilitate the identifica-
tion of specific genes and novel pathways relevant for lin-
eage differentiation.
The integration of gene expression signals and structural
and functional genomic information allowed the applica-
tion of different bioinformatics approaches to identify
and characterize higher-order organization of genomic
expression during commitment phase of myelopoiesis,
and to shed light on the complex network of biological
mechanisms of lineage choice. We applied two proce-
dures to upgrade the information content of transcrip-
tional data through the analysis of chromosomal
distribution of expression and functional features. In par-
ticular, a modified version of LAP approach [20] was
employed to search for genomic regions characterized by
consistently high or low transcriptional levels during the
commitment phase, while REEF software was used toBMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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identify chromosomal regions enriched in differentially
expressed genes.
LAP selected a single highly expressed and 21 weakly
expressed chromosomal regions, which are stably silenced
in all phases of commitment. It is noteworthy that the
70% of regions weakly expressed in CD34+ cells are stably
low transcribed during commitment and include a
number of differentially expressed genes statistically
lower than expected (p-value = 0.002). It is further note-
worthy that 85% of these regions are weakly expressed
also in terminally differentiated cells (data not shown).
These results support the hypothesis that there might be a
positional regulation of gene expression, along myelopoi-
esis, accounting for gene silencing patterns that correlate
with genomic position. In addition this positional regula-
tion seems to be stable from stem cells towards more dif-
ferentiated cells.
A consistent overlap was found among weakly expressed
regions highlighted by LAP and clusters of genes related to
functional modules silenced during myelopoiesis, identi-
fied using REEF in association with Gene Ontology anno-
tation. Indeed, the transcriptome mapping analysis was
performed on gene expression data matrix, representing a
subset of genome, while clusters of functional module
genes were identified among the whole set of genomic
genes. Deeper analysis was performed on a restricted
number of weakly expressed regions overlapping clusters
of functional modules genes, selected by lowering the q-
value threshold to 0.01. Within these regions we found a
number of genes functionally related to non-hematopoi-
etic organs (such as synaptic transmission, neurogenesis
or visual perception genes) that could not previously be
identified by classical Gene Ontology terms enrichment
analysis.
The application of REEF software to the genome level
analysis of the distribution of differentially expressed
genes during commitment phase allowed the identifica-
tion of clusters of differentially expressed genes, each
involved in a specific lineage differentiation process and
representing a potential biologically relevant chromatin
domain. In particular, results concerning monoblasts are
reported in details and are remarkably interesting, because
they suggest a clear association between cluster regions of
up-regulated genes and biological functions related to
defense immunity, as well as overall common trend in
gene expression within these regions, thus supporting the
hypothesis that they could be chromatin domains rele-
vant for monocytic function. Even if it was at least par-
tially known that some of these genes are organized as a
cluster on the genome, it is noteworthy that these regions
have been identified through the computational
approach used for the analysis of gene expression data.
Then other genomic regions, relevant both for myelopoi-
esis and other biological processes, could be identified by
means of the same integrated computational approach.
The identification of individual chromosomal regions sta-
bly silenced during myelopoiesis, partially overlapping
with specific chromosomal areas containing genes
devoted to non-myelopoietic functions, and of a number
of chromosomal regions containing clusters of genes reg-
ulated in a lineage-dependent manner, seems to support
the existence of relationships among structural and func-
tional characteristics of the genome. In particular, impor-
tant relationships between expression, biological function
and genomic position of genes, and the presence of bio-
logically relevant "chromatin domains" were identified in
myelopoiesis, which can be considered a model system
for cell differentiation. This is clearly exemplified by the
fact that clusters of silent genes are mainly stable during
differentiation and contain genes involved in develop-
ment or function of non-hematopoietic organs, thus indi-
cating the involvement of positional gene expression
regulation in maintaining tissue specific patterns of
expression. We also might suppose the involvement of
epigenetic mechanisms in regulating transcription from
contiguous genetic loci and that epigenetic events could
account for directing CD34+ cells differentiation capabil-
ities, with finer mechanisms involved in regulating differ-
entially expressed genes. The data reported so far show
that the analysis of gene expression profiles and functions
in the context of genomic position could success in iden-
tifying and characterizing particular genomic regions pre-
senting correlations between gene function and
expression. However, further studies are required to better
characterize mechanisms governing positional regulation
of gene expression.
Conclusion
This work presents a genomic approach applied to the
analysis of gene expression profiles during myeloid differ-
entiation, which substantiated the existence of relation-
ships between genomic position, biological function and
expression patterns of genes. These correlations have been
demonstrated through the identification of chromatin
domains including genes with coordinated expression,
relevant for specific lineages function in the context of
myelopoiesis.
An important result of the study was the collection of gene
expression profiles describing transcriptomes of myeloid
differentiating cells, providing the most comprehensive
dataset covering all lineages and including both stem/pro-
genitor, precursor and terminally differentiated cells.
Gene expression data analysis provided relevant lists of
genes involved in myelopoiesis, and in particular in the
commitment phase of lineage choice.BMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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Methods
Gene expression profiling of primary hematopoietic cells
Human CD34+ cells were purified from umbilical cord
blood (CB) samples as previously described [56,62]:
mononuclear cells were isolated by Ficoll-Hypaque gradi-
ent separation, washed twice with PBS, and then CD34+
cells separated using a magnetic cell sorting procedure
(EasySep® Human CD34 Positive Selection Kit, StemCell
Technologies).
Additional CD34+ samples were obtained from bone
marrow (BM), following the same protocol used for CB
samples, or from peripheral blood (PB) as already
described [63,64].
Briefly, PB hemopoietic stem and progenitor cells, were
obtained from healthy donors who received recombinant
human G-CSF (Lenograstim, Rhone-Poulenc Rorer,
Milan, Italy), administered subcutaneously at 10 µg/kg
per day for 5–6 days. Hematopoietic stem/progenitor
CD34+ cell purification was then performed as above
described.
Normal human erythroblasts were obtained from CB
CD34+ hematopoietic progenitors cultured in IMDM
(Euroclone) supplemented with 20% BIT (Stem Cell
Technologies), 50 ng/ml SCF and 4 U/ml Erythropoietin
(R&D Systems, Minneapolis, MN) for 8–10 days [58]. Dif-
ferentiation of CD34+ cells was monitored daily by mor-
phological analysis of May and Grunwald – Giemsa
(MGG) stained cytospins and by flow-cytometric analysis
of glycophorin A (GPA) surface antigen expression, using
the phycoerythrin (PE)-conjugated mouse anti-human
GPA monoclonal antibody (MoAb) (Becton Dickinson
Systems, Mountain View, CA, USA).
Monoblasts (CD14+ precursors) and myeloblasts (CD14-
precursors) were obtained by in vitro differentiation of CB
derived CD34+ cells performed as already described [56].
Briefly, CB CD34+ cells were cultured in IMDM added
with 20% FCS (Bio-Whittaker, Walkersville, MD, USA), in
the presence of human hematopoietic cytokines: SCF (50
ng/ml), Flt3-ligand (Flt3-l) (50 ng/ml), IL-11 (50 ng/ml),
IL-6 (10 ng/ml), IL-3 (10 ng/ml) and G-CSF (10 ng/ml)
(all from R&D Systems, Minneapolis, MN, USA). After 7
days of culture, hematopoietic cells were analyzed, by
flow cytometry, for CD14 antigen expression, estimated at
about 25–30% of the entire cell population. Then mono-
blasts (CD14+) and myeloblasts (CD14-) cell fractions
were obtained by immunomagnetic separation using the
MACS technology (Miltenyi). Differentiation of CD34+
cells was monitored by morphological analysis of MGG-
stained cytospins and by flow-cytometric analysis of
CD34, CD38 and CD14 surface antigen expression.
Megakaryoblasts were also obtained by in vitro differenti-
ation of CD34+ cells performed as already described [57].
Briefly, megakaryocytes were obtained from CD34+ cells
cultivated in serum-free medium supplemented with 50
ng/mL SCF and 100 ng/mL thrombopoietin (TPO; Gen-
zyme, Boston, MA) for 14–16 days and subsequently
selected by means of a magnetic beads sorting procedure
using monoclonal antibody directed against CD41a anti-
gen (Dako, Milan, Italy).
Normal human monocytes were selected from the Ficoll
separated peripheral blood (PB) mononuclear cells of
adult samples by means of magnetic microbeads conju-
gated with mouse monoclonal (Mo) anti-human CD14
antibody (Ab) (Miltenyi, Auburn, CA) [34].
Human granulocytes were initially collected from cell pel-
lets obtained by Ficoll separation of PB samples. Erythro-
cytes contained in cell pellets were removed by means of
osmotic lysis. Neutrophils (CD16+ fraction) and Eosi-
nophils (CD16- fraction) were then purified using mag-
netic microbeads conjugated to mouse Mo anti-human
CD16 Ab (Miltenyi, Auburn, CA) [34].
The immunomagnetic systems used to collect primary cell
populations always yielded a purity higher than 90%, as
assessed by flow cytometry and morphological analysis
(May and Grunwald – Giemsa staining)(Additional file
8). Total cellular RNA was isolated from 0.5–1 × 106 cells
of each analyzed sample, by means of RNeasy Mini Kit
(Qiagen, Valencia, CA) following manufacture's recom-
mendations. Disposable RNA chips (Agilent RNA 6000
Nano LabChip kit) were used to determine the concentra-
tion and quality of RNA samples using Agilent 2100 bio-
analyzer.
Gene expression profiles were obtained using Affymetrix
HG-U133A GeneChip arrays which contain more than
22,000 probesets. RNA samples from cells of different
donors were pooled to obtain 5 µg of total cellular RNA
that were used for target synthesis according to the proto-
col supplied by the manufacturer (Affymetrix, Santa Clara,
CA). Biotin-labeled cRNA was synthesized by means of
Affymetrix One Cycle Target Labeling and Control Rea-
gents Kit and subsequently controlled for quality and con-
centration using the Agilent 2100 bioanalyzer system.
Labeled cRNA (15 µg) was fragmented as described in the
Affymetrix GeneChip protocol. The fragmented cRNAs
were then hybridized to Affymetrix HG-U133A GeneChip
arrays for 16 hours. GeneChips were washed and stained
by means of Affymetrix GeneChip Fluidics Station 450
using the instrument's standard Eukaryotic_GE_WS2 pro-
tocol with antibody-mediated signal amplification. Chips
were scanned using the Affymetrix GeneChip Scanner
3000.BMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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Gene expression database annotation and construction
The proprietary gene expression collection of 20 samples,
some of them previously described in [34,56,57,64], has
been integrated with 4 publicly available samples from
Stegmaier and co-workers [65], regarding monocytes
(CL2002042640AA and CL2002042641AA) and neu-
trophils (CL2002042637AA and CL2002042638AA).
Complete information on gene expression data are avail-
able at our web site [66]. Robust multi-array average
(RMA) procedure was applied to the entire set of raw sig-
nals (i.e. .CEL files) in order to background adjust and
normalize microarray intensities and to generate gene
expression values. GCOS software and Affymetrix abso-
lute analysis algorithm were used to evaluate signal specif-
icity and reliability (Probeset Detection call: P, present; M,
marginal; A, absent).
To link expression profiles to chromosomal locations
Affymetrix probesets have been re-annotated using the
genomic information available at the GeneAnnot data-
base of Weizmann Institute (Release 13)[35]. GeneAnnot
provides a revised and improved annotation of Affymetrix
probes, whose assignment to GeneCardsIDs is ranked by
sensitivity and specificity scores. In GeneAnnot, probesets
have been related to GeneCards genes by direct sequence
comparison of probes to GenBank, RefSeq and Ensembl
mRNA sequences and sensitivity and specificity scores
have been assigned to each probeset to gene match. After
re-annotation, the analysis of myelopoiesis transcrip-
tional data was limited to those probesets associated to a
unique human gene and showing both sensitivity and
specificity score of 1. Finally, each GeneCardsID was asso-
ciated to the corresponding EntrezGeneID using GeneA-
LaCart [67].
Since the computational tools to identify differentially
expressed or enriched genomic regions require each chro-
mosomal position being represented by a single expres-
sion signal, once re-annotated, the original database has
been filtered to eliminate Affymetrix probeset redun-
dancy. Thus, in the case of multiple probesets mapping to
the same EntrezGeneID, a jackknifing procedure was
applied to integrate different expression data vectors, per-
taining to different probesets, in a single vector referring
to a unique gene and to a single chromosomal position.
Specifically, for any gene g represented by N probesets, the
N vectors of median expression values was calculated for
each block of N-1 probesets, obtained recursively exclud-
ing the i-th probeset (i = 1,...,N). Then, the Spearman cor-
relation coefficient between the vector of median values
and the expression vector of the excluded probeset has
been calculated. Finally, the probesets with a Spearman
correlation coefficient with the vector of median expres-
sion values lower than 0.5 were discarded. The remaining
probesets were used to calculate a unique vector of
median values associated to gene g.
The genomic position of each gene has been defined using
the start and end coordinates of the corresponding
KnownGene at the UCSC database. It has to be noted that
the majority of EntrezGeneIDs resulted associated to
more than one KnownGeneIDs (such as to different tran-
scripts) and to different genomic positions. As such, in the
case that the multiple genomic positions of a gene were in
the same chromosome and overlapped or close to each
other, the gene width was defined as the maximum
genomic region covered by the different KnownGeneIDs
elements pertaining to the given EntrezGeneID, and rep-
resenting the coverage of the gene considered as a tran-
scriptional unit.
The set of expression vectors associated each to a unique
gene and to a well established genomic position consti-
tuted the myelopoiesis gene expression data matrix used
for the subsequent bioinformatic analyses.
Identification of genomic regions with homogeneous 
expression characteristics and enrichments
The final data matrix was analyzed using SAM [68] to
identify genes whose expression is regulated during the
myelopoiesis commitment phase, such as genes resulting
to be differentially expressed in the different pairwise
comparisons between hematopoietic stem cells (CD34+)
and each of the four precursors cell types.
LAP
Locally Adaptive Procedure (LAP) is a bioinformatic tool
developed under R statistical environment for the identi-
fication of differentially expressed chromosomal regions,
which accounts for variations in gene distance and density
[20]. LAP procedure consists of three main steps: (1) com-
putation of a statistic for ranking probes in order of
strength of the evidence for an expression characteristic;
(2) adaptive bandwidth smoothing of the statistic after
sorting the statistical scores according to the chromo-
somal position of the corresponding genes and (3) appli-
cation of a permutation test to identify differentially
expressed chromosomal regions with a q-value correction
for multiple tests. In this context, LAP was applied to scan
the human genome and identify clusters of silent and of
highly expressed genes during the various phases of mye-
lopoiesis.
REEF
REEF (REgionally Enriched Features) [21] is a software for
identifying genomic regions enriched in specific features,
such as a class or group of genes homogeneous for expres-
sion and/or functional characteristics.BMC Genomics 2007, 8:264 http://www.biomedcentral.com/1471-2164/8/264
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The method for the calculation of local feature enrich-
ment uses test statistic based on the hypergeometric distri-
bution applied genome-wide by using a sliding window
approach and adopting the False Discovery Rate for con-
trolling multiplicity. In particular, REEF takes as input a
list of reference features (RF; e.g. all genes contained in the
myelopoiesis gene expression data matrix) mapped to a
genomic DNA sequence, a list of selected features (SF)
among the RF (e.g. a set genes specifically expressed in a
given cell type), along with their genomic positions and
the number and the length of chromosomes in the con-
sidered genome. Once selected the size of the sliding win-
dow and the shift between adjacent windows, the
significance of regional enrichment in SF observed in each
window, is calculated. Let S be the total number of SF over
the entire genome, R  the total number of RF  over the
entire genome, and r the number of RF in a given window
(with R ≥ r and S ≥ r), then the probability of observing by
chance at least k SF out of r RF in the window, is the poin-
twise significance of the observed numbers of SF in the
window, as calculated by using the Hypergeometric Dis-
tribution. This probability is then used to calculate the
corresponding q-value, which is in turn applied to select
genome-wide significantly enriched regions.
In this context, REEF was used to identify regions enriched
in genes differentially expressed in specific differentiation
lineages or in genes encoding products involved in spe-
cific functional modules.
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